Update: SpaceX postponed Friday's launch. The news liftoff is expected Saturday, November 18, 2023 with a 20-minute window opening at 8:00 a.m. ET.
By Marcia Dunn
SpaceX is aiming for another test flight of its mega rocket on Friday after getting final approval from federal regulators.
The first launch of Starship ended in an explosion minutes after lifting off from South Texas in April.
The Federal Aviation Administration issued its license Wednesday, noting that SpaceX has met safety, environmental and other requirements to launch again. Elon Musk's rocket company said it was targeting Friday morning.
After the self-destruct system blew up the rocket over the Gulf of Mexico, SpaceX made dozens of improvements to the nearly 400-foot (121-meter) rocket and to the launch pad, which ended up with a large crater beneath it.
SpaceX has a $3 billion NASA contract to land astronauts on the lunar surface as early as 2025, using the spacecraft.
A month ago, the FAA completed its safety review of the upcoming Starship launch. It needed more time to wrap up its environmental review. No one was injured in the first attempt, but the pad was heavily damaged as the rocket's 33 main engines ignited at liftoff.
The U.S. Fish and Wildlife Service later reported that concrete chunks, steel sheets and other objects were hurled thousands of feet (hundreds of meters) from the pad. It also said a plume of pulverized concrete sent material several miles (up to 10 kilometers) away.
Wildlife and environmental groups sued the FAA over what they considered to be the FAA’s failure to fully consider the environmental impacts of the Starship program near Boca Chica Beach.
Plans call for the test flight to last 1 /1/2 hours and fall short of a full orbit of Earth. The spacecraft would go eastward, passing over the Atlantic, Indian and Pacific oceans before ditching near Hawaii. Nothing of value will be on board.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Updated November 17, 2023 at 8:53 a.m. ET with time for new launch attempt.
An FDA panel has recommended the low-dose Pfizer vaccine for kids ages five to 11. The recommendation now cues up the FDA to authorize the vaccine. Next week, the CDC will consider its own authorization. Once signed off by the CDC, the Pfizer vaccine can be administered in children immediately. Dr. Christina Johns, Senior Medical Advisor at PM Pediatrics, joined Cheddar's Search for a Cure.
Dr. Vivek Cherin, Internal Medicine Physician at Amita Health, joined Cheddar's Search for a Cure to break down what we need to know about eligibility and availability of COVID-19 vaccine boosters.
World leaders will converge this weekend at the 2021 G20 Summit in Rome and the UN COP26 conference in Glasgow with the climate crisis on the agenda. Lord Adair Turner, chair of the Energy Transitions Commission, joined Cheddar to discuss what people can expect to come out of the climate-focused conferences. Turner also noted that one of the biggest hurdles for the attending nations will be coming to a uniform decision on expanding on the Paris Climate Accord goals that have become insufficient to prevent global warming by 1.5 degrees celsius.
Nicole Lambert, President at Myriad Genetics joins ChedHER to discuss how to expand access to genetic testing for all women, and how her experience as a 'pre-vivor' motivates her role in the industry.
Carlo and Baker cover Facebook's big rebrand, the latest on Biden's economic agenda and more. Plus, ranking the best Halloween candy and the worst couple's costumes.
Proptech startup Juno recently raised $20 million in a Series A funding round. The company says the funds will be used to further its mission of building sustainable and affordable apartment buildings across the United States. Juno Co-Founder and CEO Jonathan Sherr joined Cheddar News' Closing Bell to discuss.
Stacey Stevens, President of iCAD, joins 'Cheddar Innovates' to discuss how 'Profound A.I. Risk' works as a short-term breast cancer risk estimation for women.
On this episode of 'Cheddar Innovates': President of iCAD breaks down how its technology is being used as a short-term breast cancer risk estimation for women; A look at Curiosity Stream's 'The Science of Thrills.'
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
